Catalyst Pharma Proxy: Executive Pay Details Revealed

Ticker: CPRX · Form: DEF 14A · Filed: 2024-04-10T00:00:00.000Z

Sentiment: neutral

Topics: proxy-statement, executive-compensation, shareholder-voting

Related Tickers: CPRX

TL;DR

Catalyst Pharma's proxy is out, showing exec pay details for 2023. Shareholders vote soon.

AI Summary

Catalyst Pharmaceuticals, Inc. filed its DEF 14A on April 10, 2024, detailing executive compensation for the fiscal year ending December 31, 2023. The filing includes information on stock awards, option awards, and other compensation for its named executive officers. Specific dollar amounts and award details are provided within the proxy statement.

Why It Matters

This filing provides shareholders with crucial information regarding how executive compensation is structured and awarded, impacting corporate governance and investor confidence.

Risk Assessment

Risk Level: medium — DEF 14A filings are routine disclosures, but they can reveal information about executive compensation and potential shareholder proposals that could impact the company's stock.

Key Players & Entities

FAQ

What is the primary purpose of a DEF 14A filing?

A DEF 14A filing, also known as a Proxy Statement, is filed by a company to solicit shareholder votes on important corporate matters, such as the election of directors and executive compensation.

When was this DEF 14A filing submitted by Catalyst Pharmaceuticals, Inc.?

This DEF 14A filing was submitted on April 10, 2024.

What fiscal year does the compensation information in this filing primarily cover?

The compensation information in this filing primarily covers the fiscal year ending December 31, 2023.

What is the Central Index Key (CIK) for Catalyst Pharmaceuticals, Inc.?

The Central Index Key (CIK) for Catalyst Pharmaceuticals, Inc. is 0001369568.

Where is Catalyst Pharmaceuticals, Inc. headquartered?

Catalyst Pharmaceuticals, Inc. is headquartered in Coral Gables, Florida.

From the Filing

0001193125-24-091926.txt : 20240410 0001193125-24-091926.hdr.sgml : 20240410 20240410162305 ACCESSION NUMBER: 0001193125-24-091926 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 19 CONFORMED PERIOD OF REPORT: 20240521 FILED AS OF DATE: 20240410 DATE AS OF CHANGE: 20240410 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001369568 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEF 14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-33057 FILM NUMBER: 24836072 BUSINESS ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 BUSINESS PHONE: (305) 529-2522 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 FORMER COMPANY: FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC. DATE OF NAME CHANGE: 20110215 FORMER COMPANY: FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc. DATE OF NAME CHANGE: 20060719 DEF 14A 1 d762054ddef14a.htm DEF 14A DEF 14A DEF 14A false 0001369568 0001369568 2023-01-01 2023-12-31 0001369568 2021-01-01 2021-12-31 0001369568 2022-01-01 2022-12-31 0001369568 cprx:ValueOfNewUnvestedAwardsMember ecd:NonPeoNeoMember 2021-01-01 2021-12-31 0001369568 cprx:SCTEquityAwardsMember ecd:NonPeoNeoMember 2021-01-01 2021-12-31 0001369568 cprx:AnnualChangeInValueOfPriorYearAwardsThatRemainUnvestedMember ecd:PeoMember 2021-01-01 2021-12-31 0001369568 cprx:ChangeInValueOfPriorYearAwardsThatVestDuringYearMember ecd:NonPeoNeoMember 2021-01-01 2021-12-31 0001369568 cprx:ChangeInValueOfPriorYearAwardsThatVestDuringYearMember ecd:PeoMember 2021-01-01 2021-12-31 0001369568 cprx:ValueOfNewUnvestedAwardsMember ecd:PeoMember 2021-01-01 2021-12-31 0001369568 cprx:SCTEquityAwardsMember ecd:PeoMember 2021-01-01 2021-12-31 0001369568 cprx:AnnualChangeInValueOfPriorYearAwardsThatRemainUnvestedMember ecd:NonPeoNeoMember 2021-01-01 2021-12-31 0001369568 cprx:AnnualChangeInValueOfPriorYearAwardsThatRemainUnvestedMember ecd:NonPeoNeoMember 2022-01-01 2022-12-31 0001369568 cprx:ValueOfNewUnvestedAwardsMember ecd:NonPeoNeoMember 2022-01-01 2022-12-31 0001369568 cprx:SCTEquityAwardsMember ecd:NonPeoNeoMember 2022-01-01 2022-12-31 0001369568 cprx:ChangeInValueOfPriorYearAwardsThatVestDuringYearMember ecd:NonPeoNeoMember 2022-01-01 2022-12-31 0001369568 cprx:ChangeInValueOfPriorYearAwardsThatVestDuringYearMember ecd:PeoMember 2022-01-01 2022-12-31 0001369568 cprx:AnnualChangeInValueOfPriorYearAwardsThatRemainUnvestedMember ecd:PeoMember 2022-01-01 2022-12-31 0001369568 cprx:ValueOfNewUnvestedAwardsMember ecd:PeoMember 2022-01-01 2022-12-31 0001369568 cprx:SCTEquityAwardsMember ecd:PeoMember 2022-01-01 2022-12-31 0001369568 cprx:SCTEquityAwardsMember ecd:NonPeoNeoMember 2023-01-01 2023-12-31 0001369568 cprx:ValueOfNewUnvestedAwardsMember ecd:NonPeoNeoMember 2023-01-01 2023-12-31 0001369568 cprx:AnnualChangeInValueOfPriorYearAwardsThatRemainUnvestedMember ecd:NonPeoNeoMember 2023-01-01 2023-12-31 0001369568 cprx:ChangeInValueOfPriorYearAwardsThatVestDuringYearMember ecd:NonPeoNeoMember 2023-01-01 2023-12-31 0001369568 cprx:SCTEquityAwardsMember ecd:PeoMember 2023-01-01 2023-12-31 0001369568 cprx:ValueOfNewUnvestedAwardsMember ecd:PeoMember 2023-01-01 2023-12-31 0001369568 cprx:AnnualChangeInValueOfPriorYearAwardsThatRemainUnvestedMember ecd:PeoMember 2023-01-01 2023-12-31 0001369568 cprx:ChangeInValueOfPriorYearAwardsThatVestDuringYearMember ecd:PeoMember 2023-01-01 2023-12-31 0001369568 1 2023-01-01 2023-12-31 0001369568 2 2023-01-01 2023-12-31 0001369568 3 2023-01-01 2023-12-31 0001369568 4 2023-01-01 2023-12-31 iso4217:USD     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934     File

View on Read The Filing